-
Phase I Dose Escalation Trial of Single Fraction Adjuvant Stereotactic Body Partial Breast irradiation (SB-PBI) For Early Stage Breast Cancer
In this study, early-stage breast cancer patients will be receiving a single fraction (radiation dose) via FDA-approved Cyberknife technology. The main goal of this study ...Phase
Interventional
-
A Phase 1b First-in-Human Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b
The purpose of the study is to determine the safety and tolerability of the antibody-drug conjugate (ADC) XMT-1536 administered as an intravenous infusion once every ...Phase
Interventional
